← Leaderboards
Anthony Ting
Athersys, Inc.
$1,448,152
Attributed
$3,006,304
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2013–17$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,006,304 · 2
By mechanism
R44$2,038,006 · 1
R42$968,298 · 1
Top collaborators
- Marc S Penn3 shared
- Mauricio Rojas3 shared
- Warren Sherman1 shared
Most similar at Athersys, Inc.
Same institution · by research overlap
- Cesario V Borlongan$4,668,563
- Robert William Mays$927,609
- Warren Sherman$110,000
- Sarah Busch$106,398
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseNovel TherapeuticsStem CellsPhase I Clinical TrialsCell TypeCell TherapyMorbidity - Disease RateBone MarrowValidationAcuteSafetyAllogenicClinical TrialsPublic Health RelevanceAnimalsAnimal ModelAdoptedAmericanAlveolarAdmission ActivityBlood CapillariesBiotechnologyAcute Myocardial Infarction
Grant awards (6)
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$293,537
R42 · FY2017 · AA · contact PI
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for$842,506
R44 · FY2016 · HL · contact PI
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$450,040
R42 · FY2016 · AA · contact PI
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for$865,500
R44 · FY2015 · HL · contact PI
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$224,721
R42 · FY2014 · AA · contact PI
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for$330,000
R44 · FY2013 · HL · contact PI